What is MaRS EXCITE?

As part of the MaRS Health services, the MaRS Excellence in Clinical Innovation Technology Evaluation (EXCITE) program is a collaboration between a range of stakeholders in the health system that work together to help innovative health technologies get to market faster and improve patient outcomes.

At the end of the program, companies will have a robust evidence package, called the EXCITE core evidentiary bundle, that they can use for both Health Canada licensing and reimbursement and purchasing reviews.

 
Beside device

  • Join EXCITE at Health Quality Transformation 2014 More...
  • Funding Opportunity: Call for Expressions of Interest for Alberta-Ontario Innovation Program More...
  • Event: Gaining Access to Capital talk: Lumira, Bloom Burton & Co. RBC, BDC, Gowlings More...
  • Event: Health Technology Forum Meetup – Demo & Mixer Night More...
  • From the MaRS EXCITE Team – “Have a Groovy Halloween!” More...
  • Dr. Murray Krahn interviewed on CBC’s Metro Morning regarding controversial PSA test More...
  • Becton Dickinson to pay $12.2B to acquire medical equipment rival Carefusion More...
  • MedTech Thursday Meetup in Toronto on November 6 More...
  • MaRS EXCITE to help bring innovative stroke recovery device to market More...
  • Kangaroo opening new Toronto West co-working space for young companies More...